Ambys Medicines
Gaetano 'Nino' Faleo has extensive work experience in the field of science. Gaetano ‘Nino’ began their career in 2010 as an Assistant Researcher at UCSF, where they also served as a Research Specialist and Postdoctoral Research Fellow. In 2019, they joined Ambys Medicines as a Senior Scientist II and was later promoted to Senior Scientist.
Gaetano 'Nino' Faleo completed their Master's Degree in Medicinal and Pharmaceutical Chemistry from Alma Mater Studiorum - Università di Bologna in 2003. Gaetano ‘Nino’ then completed a Master Thesis in Toxicology at INRA Jouy-en-Josas in 2002-2003. In 2004-2007, they completed their Doctor of Philosophy (Ph.D.) in Organ Transplantation at Università degli Studi di Foggia. Gaetano ‘Nino’ then spent a year as a Visiting Scholar in Organ Transplantation at the University of Pittsburgh in 2006-2007. Finally, they were a Postdoctoral research fellow in Pancreatic Islet Transplantation at the University of Miami from 2007-2010.
This person is not in any offices
Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today.